Case Challenge

Management of Emergent Depression and Suicidal Ideation During HCV Therapy

Source: Management of Depression and HCV: Novel Data, Best Practices, and Case Challenges

Management of Emergent Depression and Suicidal Ideation During HCV Therapy

Faculty:

Alfredo Alberti, MD

CME CREDIT INFORMATION

Release Date: 10/01/08

Expiration Date: 09/30/09

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss the incidence of and strategies for monitoring depression during interferon-based HCV antiviral therapy
Describe strategies for managing depression that emerges during HCV therapy
Articulate how the shortening of treatment can be used in genotype 2/3 HCV–infected patients who develop depressive symptoms during therapy
Recall the incidence and management strategies for the development of suicidal ideation during HCV therapy

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.